AG Personalisierte Genomik

Lead: Prof. Dr. rer. nat. Thomas Illig

 

Molecular analyses and related data are getting more and more important to decipher the pathoetiology of complex and rare diseases. These data are increasingly forming the basis for preventive measures and personalized therapies. This is especially the case in the field of cancer research, prevention, and treatment. The team “Personalized Genomics” is mainly engaged in the molecular and functional analysis as well as in the diagnostics of human malignancies of the blood.

Our research activities are organized in two junior research groups lead by Anke Bergmann and Tim Ripperger. Besides their individual foci, they are jointly working on the discovery of disease-causing (epi-)genomic alterations in rare disease at the bedside and study their consequences at the bench.

 

The team is divided into two Junior Research Groups: